Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
US7771927B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 7, 1998 |
| Grant date | Aug 10, 2010 |
| Priority date | — |
| Expiry date | Jul 7, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/10022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a nucleic material, in isolated or purified state, and a nucleotide fragment comprising a nucleotide sequence selected from the group consisting in (i) the sequences SEQ ID NO: 112, SEQ ID NO:114, SEQ ID NO: 117, SEQ ID NO: 120, SEQ ID NO. 124, SEQ ID NO: 130, SEQ ID NO: 141 and SEQ ID NO: 142, (ii) the complementary sequences of sequences (i); and (iii) the sequences equivalent to sequences (ii) and (iii), in particular the sequence having for every series of 100 contiguous monomers, at least 50%, preferably 70% homology with sequences (i) and (ii) respectively. The invention also concerns their uses for detecting a retrovirus associated with multiple sclerosis and/or rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.